| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/08/2014 | CA2599304C Cell targeting conjugates |
| 07/08/2014 | CA2596210C Combination therapies using hdac inhibitors |
| 07/08/2014 | CA2595063C Emulsified composition for dilution and cancer vaccine composition |
| 07/08/2014 | CA2589828C Compositions comprising a taxoid and a benzimidazole carbamate for the treatment of cancer |
| 07/08/2014 | CA2520255C Tie-2 modulators and methods of use |
| 07/08/2014 | CA2480712C Chondrocyte therapeutic delivery system |
| 07/08/2014 | CA2472633C S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 07/08/2014 | CA2463816C Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 07/08/2014 | CA2415422C Chromosome 3p21.3 genes are tumor suppressors |
| 07/08/2014 | CA2395369C Cytokine zcyto18 |
| 07/08/2014 | CA2350395C Nucleotide and protein sequences of nogo genes and methods based thereon |
| 07/03/2014 | WO2014105810A1 Prolactin receptor binding proteins and uses thereof |
| 07/03/2014 | WO2014105644A1 Nanoparticle compositions of albumin and paclitaxel |
| 07/03/2014 | WO2014104924A1 Antineoplastic agent (alternatives) |
| 07/03/2014 | WO2014104757A1 2,3-dihydro-isoindole-1-on derivative as btk kinase suppressant, and pharmaceutical composition including same |
| 07/03/2014 | WO2014104414A1 Salts and crystal forms |
| 07/03/2014 | WO2014104372A1 Halogen-substituted heterocyclic compound |
| 07/03/2014 | WO2014104270A1 ANTIBODY RECOGNIZING FOLATE RECEPTORS α AND β |
| 07/03/2014 | WO2014104171A1 Skin-exterior anti-ageing composition and production method therefor |
| 07/03/2014 | WO2014104165A1 Heterodimerized polypeptide |
| 07/03/2014 | WO2014103608A1 Vaccine for hpv infection and/or hepatitis b containing hpv/hbs chimeric protein as active ingredient |
| 07/03/2014 | WO2014103475A1 Skin-exterior anti-ageing composition and production method therefor |
| 07/03/2014 | WO2014103321A1 Pdk4 inhibitor and use thereof |
| 07/03/2014 | WO2014103310A1 Vaccine prepared utilizing human parainfluenza virus type 2 vector |
| 07/03/2014 | WO2014102889A1 Antitumor agent and method for producing same |
| 07/03/2014 | WO2014102817A1 Substituted phthalazin-1 (2h)-one derivatives as selective inhibitors of poly (adp-ribose) polymerase-1 |
| 07/03/2014 | WO2014102595A1 Composition for use as a support therapy for treatment of tumours, aids and leukaemia |
| 07/03/2014 | WO2014102540A1 Vaccines against hepatitis b virus |
| 07/03/2014 | WO2014102430A1 Therapeutic treatment of t- and b-acute lymphoblastic leukemia and human lymphomas by inhibition of the interleukin-7 receptor (il-7r) |
| 07/03/2014 | WO2014102378A1 Azaindole derivatives as inhibitors of protein kinases |
| 07/03/2014 | WO2014102377A1 Azaindole derivatives as multi kinase inhibitors |
| 07/03/2014 | WO2014102376A1 Protein kinase inhibitors |
| 07/03/2014 | WO2014102220A1 Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells |
| 07/03/2014 | WO2014101718A1 Methods and compositions for treating and/or preventing a disease or disorder associated with abnormally high level of motichondria factor 4 |
| 07/03/2014 | WO2014101356A1 Gamabufotalin liposome, preparation method therefor and applicationthereof |
| 07/03/2014 | WO2014101339A1 Cyanine dye compound and preparation method therefor, and dual-function agent for photodynamic therapy and preparation method therefor |
| 07/03/2014 | WO2014101295A2 Isoxazole derivative that inhibits activity of janus kinases (jaks) |
| 07/03/2014 | WO2014101287A1 Fusion protein of therapeutic polypeptide with improved pharmacokinetic profile and use thereof |
| 07/03/2014 | WO2014101134A1 Folic acid derivative, and preparing method and application thereof |
| 07/03/2014 | WO2014101038A1 Method for preparing drug-loaded microspheres |
| 07/03/2014 | WO2014100857A1 Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy |
| 07/03/2014 | WO2014100852A1 Inhibition of cancer growth and metastasis |
| 07/03/2014 | WO2014071067A3 Treatment and diagnosis of colon cancer |
| 07/03/2014 | WO2014067960A3 Functionalized 9-bromo-camptothecin derivatives |
| 07/03/2014 | WO2014041088A3 Combined treatment with netrin-1 interfering drug and chemotherapeutic drug |
| 07/03/2014 | US20140187772 Pyrazole compounds useful as protein kinase inhibitors |
| 07/03/2014 | US20140187601 Antisense oligonucleotide modulation of raf gene expression |
| 07/03/2014 | US20140187485 Novel receptor nucleic acids and polypeptides |
| 07/03/2014 | US20140187441 Amplification of cyp24 and uses thereof |
| 07/03/2014 | US20140186400 Methods and compositions for treating autoimmune diseases |
| 07/03/2014 | US20140186368 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 07/03/2014 | US20140186349 Human cdr-grafted antibody and antibody fragment thereof |
| 07/02/2014 | EP2749641A1 Cancer stem cell isolation |
| 07/02/2014 | EP2749639A1 Proliferating agent for monocyte, culture medium for proliferating monocyte, method for producing monocyte, method for producing dendritic cell, and method for producing dendritic cell vaccine |
| 07/02/2014 | EP2749573A1 Agr2 blocking antibody and use thereof |
| 07/02/2014 | EP2749572A1 Novel anti-ddr1 antibody having anti-tumor activity |
| 07/02/2014 | EP2749568A1 Cell dna synthesis prevention and cell proliferation inhibition polypeptide and use thereof |
| 07/02/2014 | EP2749559A1 5-substituted isoindoline compounds |
| 07/02/2014 | EP2749295A1 Radiopharmaceutical and pharmaceutical kit |
| 07/02/2014 | EP2749294A1 Anti-tumor agent and anti-tumor kit |
| 07/02/2014 | EP2749292A1 Tumor chemotherapeutic drug formulation and preparation method thereof |
| 07/02/2014 | EP2748336A1 Methods for determining responsiveness to a dihydrofolate reductase inhibitor |
| 07/02/2014 | EP2748334A1 A protein involved in detection of cancer metastasis and a treatment thereof |
| 07/02/2014 | EP2748203A1 Fn14 binding proteins and uses thereof |
| 07/02/2014 | EP2748202A1 Bispecific antigen binding molecules |
| 07/02/2014 | EP2748201A1 Bispecific t cell activating antigen binding molecules |
| 07/02/2014 | EP2748200A1 Fc-free antibodies comprising two fab fragments and methods of use |
| 07/02/2014 | EP2748199A1 Anti-ox40 antibodies and methods of using the same |
| 07/02/2014 | EP2748195A1 Anti-mcsp antibodies |
| 07/02/2014 | EP2748168A2 Inhibitors of nedd8-activating enzyme |
| 07/02/2014 | EP2748164A1 Bicyclic heteroaromatic compounds |
| 07/02/2014 | EP2748159A1 Serine/threonine pak1 inhibitors |
| 07/02/2014 | EP2747784A1 Method for inhibiting cellular activation by insulin-like growth factor-1 |
| 07/02/2014 | EP2747783A2 Biological materials related to c-met |
| 07/02/2014 | EP2747781A1 Bispecific antibodies specific for t-cell activating antigens and a tumor antigen and methods of use |
| 07/02/2014 | EP2747761A1 Methods of treating cancers with therapeutic nanoparticles |
| 07/02/2014 | EP2747755A1 Cdk9 inhibitors in the treatment of midline carcinoma |
| 07/02/2014 | CN103906757A 盐酸伊达比星的结晶 Idarubicin hydrochloride crystals |
| 07/02/2014 | CN103906751A 作为晚期SV40因子（LSF）抑制剂用于治疗癌症的[1,3]二氧杂环戊烯并[4,5-g]喹啉-6(5H)-硫酮和[1,3]二氧杂环戊烯并[4,5-g][1,2,4]三唑并[1,5-a]喹啉衍生物 As late SV40 factor (LSF) inhibitors for the treatment of cancer [1,3] dioxole and [4,5-g] quinoline -6 (5H) - thione and [1,3] dioxole and [4,5-g] [1,2,4] triazolo [1,5-a] quinoline derivatives |
| 07/02/2014 | CN103906747A 卡巴他赛及其中间体的制备方法 Preparation cabazitaxel and its intermediates |
| 07/02/2014 | CN103906742A 硒吩稠合芳族化合物和其制备方法 Selenophene fused aromatic compounds and their preparation |
| 07/02/2014 | CN103906738A 用于治疗趋化因子介导的疾病的新的二取代的3,4-二氨基-3-环丁烯-1,2-二酮化合物 For the treatment of chemokine mediated disease novel 3,4-disubstituted-amino-3-cyclobutene-1,2-dione compound |
| 07/02/2014 | CN103906735A 新芳基-喹啉衍生物 New aryl - quinoline derivative |
| 07/02/2014 | CN103906730A Parp抑制剂 Parp inhibitors |
| 07/02/2014 | CN103906536A 恶病质治疗 Cachexia treatment |
| 07/02/2014 | CN103906516A 用于增强T细胞介导的免疫应答的β-内酰胺化合物 Β- lactam compounds for enhancing the immune response of T cell-mediated |
| 07/02/2014 | CN103906515A 治疗黏液表皮样癌的方法 Mucoepidermoid cancer treatment method |
| 07/02/2014 | CN103898128A 香菇C91-3菌株的Latcripin-16基因片段、编码蛋白及制备方法 Latcripin-16 gene fragment mushrooms C91-3 strains encoding protein and preparation method |
| 07/02/2014 | CN103898118A 抑制人肌丝联合蛋白1L2基因表达的siRNA及其表达载体和应用 SiRNA inhibition of human muscle wire joint 1L2 gene expression and protein expression vectors and applications |
| 07/02/2014 | CN103898117A 抑制人细胞分裂周期蛋白42基因表达和增殖的miRNA模拟物及其表达载体和应用 Inhibit cell division cycle protein 42 gene expression and proliferation of miRNA mimics and expression vectors and applications |
| 07/02/2014 | CN103898116A Smurf1蛋白或其抑制剂在制备治疗或诊断结肠癌产品中的应用 Smurf1 protein or inhibitor in the manufacture of products in the treatment or diagnosis of colon cancer Application |
| 07/02/2014 | CN103898069A 鉴定脆性组氨酸三联体(Fhit)相互作用的方法及其用途 Identification of fragile histidine triad (Fhit) interaction and its use |
| 07/02/2014 | CN103898058A 一种新型胶质瘤干细胞的三维培养方法及其应用 A new three-dimensional culture of glioma stem cells and Its Application |
| 07/02/2014 | CN103898051A 提高免疫反应性的方法 Enhance the immune response of the method |
| 07/02/2014 | CN103898050A 高效分泌一氧化氮的重组间充质干细胞及其制备方法与应用 Efficient secretion of nitric oxide between recombinant mesenchymal stem cells and its preparation method and application |
| 07/02/2014 | CN103897969A 一种甲鱼血滋补酒及其制备方法 One kind of turtle blood tonic and its preparation method |
| 07/02/2014 | CN103897067A 一种治疗肿瘤的重组多肽 A recombinant polypeptide tumors |
| 07/02/2014 | CN103897059A 抗cd20抗原的抗体l5h7及其应用 Anti-cd20 antigen antibody l5h7 its application |
| 07/02/2014 | CN103897058A 结合cxcr4的人类抗体及其用途 Binding cxcr4 human antibody and uses thereof |
| 07/02/2014 | CN103897052A 一种白细胞介素-24突变体及其制备方法和应用 One kind of mutant IL-24 and its preparation method and application |